Bruker Corporation (BRKR)
Cash conversion cycle
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Days of inventory on hand (DOH) | days | 227.01 | 243.54 | 238.40 | 214.51 | 241.18 |
Days of sales outstanding (DSO) | days | 65.05 | 66.23 | 68.18 | 62.93 | 61.58 |
Number of days of payables | days | 49.77 | 50.98 | 53.16 | 44.53 | 46.89 |
Cash conversion cycle | days | 242.29 | 258.79 | 253.42 | 232.91 | 255.87 |
December 31, 2024 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= 227.01 + 65.05 – 49.77
= 242.29
The cash conversion cycle for Bruker Corporation has shown fluctuations over the past five years. As of December 31, 2020, the company's cash conversion cycle was reported at 255.87 days, indicating a relatively lengthy period for converting resources into cash.
Over the subsequent years, Bruker Corporation made some improvements in its cash conversion cycle. By December 31, 2021, the cycle decreased to 232.91 days, suggesting a more efficient management of working capital and cash flow.
However, there was a slight increase in the cash conversion cycle by December 31, 2022, as it rose to 253.42 days. This uptick could indicate potential challenges in converting investments into cash within the expected timeframe.
By December 31, 2023, the cycle extended further to 258.79 days, possibly raising concerns about the company's liquidity and operational efficiency.
In the latest year reported, December 31, 2024, Bruker Corporation managed to reduce its cash conversion cycle to 242.29 days. While this improvement is positive, the company may still need to focus on further optimizing its cash conversion processes to enhance overall financial performance and liquidity.
Peer comparison
Dec 31, 2024